Amgen Inc (LTS:0R0T)
$ 269.5 0 (0%) Market Cap: 160.64 Bil Enterprise Value: 212.02 Bil PE Ratio: 38.26 PB Ratio: 21.34 GF Score: 90/100

Q1 2021 Amgen Inc Earnings Call Transcript

Apr 27, 2021 / 09:00PM GMT
Release Date Price: $255 (-0.39%)
Operator

My name is Erica, and I will be your conference facilitator today for Amgen's First Quarter 2021 Financial Results Conference Call. (Operator Instructions) I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.

Arvind Sood;Robert A. Bradway
Amgen Inc. - VP of IR;Amgen Inc. - Chairman, CEO &

Erica, thank you. Good afternoon, everybody. Welcome to our Q1 call. I think the 2 key themes for this quarter, our continued focus on volume-driven growth and pipeline advancement. Lots to cover, but we'll do our best to stick to an efficient format of limited prepared comments and addressing your one best question. The slides have been posted. Just a quick reminder that we'll use non-GAAP financial measures in our presentation and some of the statements will be forward-looking statements. Our SEC filings identify factors that could cause our actual results to differ materially.

So with that, I would like to turn the call over to our Chairman and CEO, Bob Bradway. Bob?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot